Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06866223 · ClinicalTrials.gov registry record · NA

Emergent Bilinguals: Child Language Proficiency and Language of Treatment

A NA study of Developmental Language Disorder and Language Impairment, sponsored by University of Houston.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06866223: Recruiting NA study of Developmental Language Disorder and Language Impairment, sponsored by University of Houston.

NCT06866223 is a NA study of Developmental Language Disorder and Language Impairment that is actively recruiting participants, run by University of Houston. The registered enrollment target is 40 participants, below the 180-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06866223, a NA study of Developmental Language Disorder and Language Impairment, is actively recruiting participants, sponsored by University of Houston.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for emergent Spanish-English bilingual children with DLD. This project will examine the relationship between language proficiency and the language of intervention, considering monolingual intervention (Spanish or English) and interleaved Spanish-English intervention with the goal of improving language outcomes and thereby strengthening long-term academic achievement

Primary Outcome

Accuracy on elicited production probes are the primary outcome measure. There are 40 probes in total. Ten for Spanish conditionals, ten English conditionals, ten Spanish complement clauses and ten English complement clauses.

Interventions

  • BEHAVIORAL Sentence recast

Study Locations (1)

Texas

  • University of Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-11-11
Est. Completion 2028-07-01
Phase NA
University of Houston

64 total trials

What NCT06866223 shows while recruiting

NCT06866223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 180-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sentence recast is the first listed.

NCT06866223 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06866223 about?

NCT06866223 is a clinical study titled "Emergent Bilinguals: Child Language Proficiency and Language of Treatment". Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for emergent Spanish-Englis...

What is the current status of trial NCT06866223?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-11-11. Estimated completion is 2028-07-01.

What conditions does trial NCT06866223 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Language Impairment.

What interventions are being tested in trial NCT06866223?

The interventions under investigation include: Sentence recast (BEHAVIORAL).

Who is sponsoring clinical trial NCT06866223?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06866223 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06866223's enrollment target sits among peer trials

40 14th of 17 higher than 3 of 17 other Developmental Language Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06866223, the US trial registry maintained by the National Library of Medicine. NCT06866223 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.